Register Login

CHEMOMAB THERAPEUTICS LTD. (CMMB)

SymbolCMMB
NameCHEMOMAB THERAPEUTICS LTD.
SectorHEALTH CARE
RegionMiddle East
IndustryBiotechnology: Pharmaceutical Preparations
AddressKIRYAT ATIDIM,BUILDING 7, TEL AVIV, 6158002, Israel
Telephone+972 773310156
Fax—
Email—
Websitehttps://www.chemomab.com
IncorporationUNDEFINED
Incorporated On—
Employees—
Fiscal Year—
Public Since—
ExchangesNASDAQ
Auditor—
Audit StatusNOT PROVIDED
Reporting Status—
CIK0001534248
Description

Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The companys lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

Additional info from NASDAQ:
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet need. The companys lead candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.

2026-04-10 17:13

New Form 3 - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001178913-26-002068 <b>Size:</b> 13 KB

Read more
2026-04-10 17:11

New Form 3 - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001178913-26-002066 <b>Size:</b> 13 KB

Read more
2026-04-10 17:07

New Form 3 - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001178913-26-002062 <b>Size:</b> 10 KB

Read more
2026-04-10 17:05

New Form 3 - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-04-10 <b>AccNo:</b> 0001178913-26-002060 <b>Size:</b> 10 KB

Read more
2026-03-31 17:03

New Form 3 - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001178913-26-001962 <b>Size:</b> 8 KB

Read more
2026-03-31 17:02

New Form 3 - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-03-31 <b>AccNo:</b> 0001178913-26-001960 <b>Size:</b> 11 KB

Read more
2026-03-19 12:33

Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

Read more
2026-03-19 12:05

CHEMOMAB THERAPEUTICS LTD. (CMMB) Files Form 6-K

Read more
2026-03-19 12:00

Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update

Read more
2026-02-17 18:49

New Form SCHEDULE 13G/A - Chemomab Therapeutics Ltd. <b>Filed:</b> 2026-02-17 <b>AccNo:</b> 0001211060-26-000005 <b>Size:</b> 11 KB

Read more